Semaglutide (Duplicate Entry)

Note. This entry is a duplicate listing of Semaglutide that appeared a second time in the source catalogue. The full research write-up — covering molecular profile, GLP-1 receptor pharmacology, the SUSTAIN and STEP clinical-trial programmes, and the cardiovascular and weight-management indications — is consolidated under the primary Semaglutide entry.

Please refer to the canonical post: Semaglutide: A Long-Acting GLP-1 Receptor Agonist for the complete profile.

---

This article is provided for educational and research purposes only. Semaglutide is a prescription medication where approved; outside of approved medical use, semaglutide research material is supplied for laboratory use only and is not intended for human consumption, diagnosis, treatment, cure, or prevention of any disease or condition. All work involving this peptide should be conducted by qualified personnel within an appropriate research setting and in compliance with applicable institutional and regulatory requirements.